Afya (AFYA) Projected to Release Earnings on Thursday

Afya (NASDAQ:AFYA) is expected to post its Q3 2026 results after the market closes on Thursday, November 12th. Analysts expect Afya to announce earnings of $0.3791 per share and revenue of $190.41 million for the quarter. Interested persons can check the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Thursday, November 12, 2026 at 5:00 PM ET.

Afya (NASDAQ:AFYA) last posted its quarterly earnings data on Friday, August 14th. The company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.40 by $0.03. The business had revenue of $187.80 million during the quarter, compared to analyst estimates of $189.62 million. Afya had a net margin of 20.55% and a return on equity of 17.58%. On average, analysts expect Afya to post $1.68 EPS for the current fiscal year and $1.77 EPS for the next fiscal year.

Afya Trading Up 1.6%

Shares of AFYA stock opened at $10.67 on Tuesday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.20 and a current ratio of 2.20. The stock has a market capitalization of $999.99 million, a P/E ratio of 6.51, a price-to-earnings-growth ratio of 1.68 and a beta of 0.43. The company has a 50 day moving average price of $13.16 and a 200 day moving average price of $14.08. Afya has a fifty-two week low of $9.66 and a fifty-two week high of $16.16.

Analyst Ratings Changes

AFYA has been the subject of several recent research reports. Zacks Research cut shares of Afya from a “hold” rating to a “strong sell” rating in a research report on Tuesday, November 3rd. Bradesco Corretora upgraded shares of Afya to an “outperform” rating and set a $17.00 price target for the company in a research note on Thursday, September 24th. Wall Street Zen raised Afya from a “hold” rating to a “buy” rating in a research report on Sunday. Morgan Stanley upgraded Afya from an “underweight” rating to an “equal weight” rating and set a $12.60 price objective on the stock in a research note on Thursday. Finally, JPMorgan Chase & Co. reduced their price objective on Afya from $19.00 to $17.50 and set an “overweight” rating on the stock in a research note on Tuesday, November 3rd. Four analysts have rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $15.18.

Insider Transactions at Afya

In other Afya news, insider Santos Welder Ferreira sold 4,161 shares of Afya stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $13.30, for a total transaction of $55,341.30. Following the completion of the sale, the insider directly owned 35,000 shares of the company’s stock, valued at $465,500. The trade was a 10.63% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

About Afya

Afya Limited is a Brazilian medical education and digital health company. Its education business offers undergraduate medical degree programs, medical residency preparation, postgraduate courses and continuing education for health professionals.

The company also provides digital tools and services for medical students and practicing physicians, including clinical reference, practice-management and learning resources. These offerings support professionals at different stages of their medical careers.

Afya traces its roots to 1999 and serves students and health professionals across Brazil through its educational institutions and digital platforms.